Reckitt Benckiser Group (LON:RB) has been given a GBX 7,000 ($94.93) price objective by equities researchers at UBS Group in a note issued to investors on Thursday, www.boersen-zeitung.de reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price target would suggest a potential upside of 2.91% from the stock’s current price.

A number of other equities analysts have also recently commented on the stock. JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a GBX 7,500 ($101.71) target price on shares of Reckitt Benckiser Group in a report on Wednesday. Morgan Stanley set a GBX 9,000 ($122.05) target price on shares of Reckitt Benckiser Group and gave the company a “buy” rating in a report on Tuesday, January 9th. Kepler Capital Markets cut their target price on shares of Reckitt Benckiser Group from GBX 7,300 ($99.00) to GBX 7,000 ($94.93) and set a “hold” rating on the stock in a report on Monday, January 8th. Liberum Capital reaffirmed a “buy” rating and issued a GBX 8,000 ($108.49) target price on shares of Reckitt Benckiser Group in a report on Tuesday, December 19th. Finally, Goldman Sachs Group set a GBX 7,070 ($95.88) target price on shares of Reckitt Benckiser Group and gave the company a “neutral” rating in a report on Monday, December 11th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of GBX 7,664.55 ($103.94).

Reckitt Benckiser Group (LON:RB) traded up GBX 2 ($0.03) during mid-day trading on Thursday, reaching GBX 6,802 ($92.24). 1,308,569 shares of the company’s stock were exchanged, compared to its average volume of 1,170,000. Reckitt Benckiser Group has a 12 month low of GBX 6,299 ($85.42) and a 12 month high of GBX 8,110.43 ($109.99). The firm has a market capitalization of $47,860.00 and a PE ratio of 2,274.92.

In related news, insider Adrian Nevil Hennah bought 2,285 shares of the firm’s stock in a transaction on Wednesday, November 8th. The shares were bought at an average cost of GBX 6,567 ($89.06) per share, for a total transaction of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair bought 2,800 shares of the firm’s stock in a transaction on Wednesday, November 1st. The shares were bought at an average price of GBX 6,597 ($89.46) per share, for a total transaction of £184,716 ($250,496.34).

TRADEMARK VIOLATION WARNING: “UBS Group Analysts Give Reckitt Benckiser Group (RB) a GBX 7,000 Price Target” was first reported by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.watchlistnews.com/ubs-group-analysts-give-reckitt-benckiser-group-rb-a-gbx-7000-price-target/1807002.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with Analyst Ratings Network's FREE daily email newsletter.